These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 34967942)

  • 21. Cost-effectiveness and threshold analysis of deep brain stimulation vs. treatment-as-usual for treatment-resistant depression.
    Kabotyanski KE; Najera RA; Banks GP; Sharma H; Provenza NR; Hayden BY; Mathew SJ; Sheth SA
    Transl Psychiatry; 2024 Jun; 14(1):243. PubMed ID: 38849334
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical outcomes, quality of life, and costs associated with implantation of vagus nerve stimulation therapy in pediatric patients with drug-resistant epilepsy.
    Helmers SL; Duh MS; Guérin A; Sarda SP; Samuelson TM; Bunker MT; Olin BD; Jackson SD; Faught E
    Eur J Paediatr Neurol; 2012 Sep; 16(5):449-58. PubMed ID: 22261080
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analyzing cost-effectiveness of ulnar and median nerve transfers to regain forearm flexion.
    Wali AR; Park CC; Brown JM; Mandeville R
    Neurosurg Focus; 2017 Mar; 42(3):E11. PubMed ID: 28245686
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of Vagus Nerve Stimulation for the Treatment of Drug-resistant Epilepsy on Patterns of Use and Cost of Health Care Services and Pharmacotherapy: Comparisons of the 24-Month Periods Before and After Implantation.
    Evans K; Stamas N; Li Q; Vincent T; Halchenko Y; Zhang L; Danielson V; Murphy J; Barion F; Lam S; Lassagne R; Berger A
    Clin Ther; 2023 Feb; 45(2):136-150. PubMed ID: 36746736
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Economic evaluation of deep-brain stimulation for Tourette's syndrome: an initial exploration.
    Dang TTH; Rowell D; Liddle J; Coyne T; Silburn P; Connelly LB
    J Neurol; 2019 Dec; 266(12):2997-3008. PubMed ID: 31485722
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Effectiveness of Vagus Nerve Stimulation in Drug-Resistant Epilepsy Correlates with Vagus Nerve Stimulation-Induced Electroencephalography Desynchronization.
    Sangare A; Marchi A; Pruvost-Robieux E; Soufflet C; Crepon B; Ramdani C; Chassoux F; Turak B; Landre E; Gavaret M
    Brain Connect; 2020 Dec; 10(10):566-577. PubMed ID: 33073582
    [No Abstract]   [Full Text] [Related]  

  • 27. Cost-utility analysis of competing treatment strategies for drug-resistant epilepsy in children with Tuberous Sclerosis Complex.
    Fallah A; Weil AG; Wang S; Lewis E; Baca CB; Mathern GW
    Epilepsy Behav; 2016 Oct; 63():79-88. PubMed ID: 27591681
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.
    Garside R; Pitt M; Anderson R; Rogers G; Dyer M; Mealing S; Somerville M; Price A; Stein K
    Health Technol Assess; 2007 Nov; 11(45):iii-iv, ix-221. PubMed ID: 17999840
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cost-effectiveness of deep brain stimulation versus treatment as usual for obsessive-compulsive disorder.
    Ooms P; Blankers M; Figee M; Bergfeld IO; van den Munckhof P; Schuurman PR; Denys D
    Brain Stimul; 2017; 10(4):836-842. PubMed ID: 28457837
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of efficiency between VNS and ANT-DBS therapy in drug-resistant epilepsy: A one year follow up study.
    Zhu J; Wang X; Xu C; Zhang X; Qiao L; Zhang X; Yan X; Ni D; Yu T; Zhang G; Li Y
    J Clin Neurosci; 2021 Aug; 90():112-117. PubMed ID: 34275533
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anterior thalamic deep brain stimulation in epilepsy patients refractory to vagus nerve stimulation: A single center observational study.
    Miron G; Strauss I; Fried I; Fahoum F
    Epilepsy Behav Rep; 2022; 20():100563. PubMed ID: 36119948
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A systematic review and economic evaluation of the clinical effectiveness and cost-effectiveness of aldosterone antagonists for postmyocardial infarction heart failure.
    McKenna C; Burch J; Suekarran S; Walker S; Bakhai A; Witte K; Harden M; Wright K; Woolacott N; Lorgelly P; Fenwick L; Palmer S
    Health Technol Assess; 2010 May; 14(24):1-162. PubMed ID: 20492762
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Add-On Deep Brain Stimulation versus Continued Vagus Nerve Stimulation for Childhood Epilepsy (ADVANCE): A Partially Randomized Patient Preference Trial.
    Suresh H; Mithani K; Warsi N; Ochi A; Otsubo H; Drake JM; Rutka JT; Kerr E; Smith ML; Breitbart S; Yau I; McRae L; Chau V; Weiss S; Jain P; Donner E; Fasano A; Gorodetsky C; Ibrahim GM
    Ann Neurol; 2024 Aug; 96(2):405-411. PubMed ID: 38822686
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vagus nerve stimulation therapy in a developing country: a long term follow up study and cost utility analysis.
    Aburahma SK; Alzoubi FQ; Hammouri HM; Masri A
    Seizure; 2015 Feb; 25():167-72. PubMed ID: 25468513
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Systematic Review of Cost-Effectiveness Analysis for Surgical and Neurostimulation Treatments for Drug-Resistant Epilepsy in Adults.
    Ngan Kee N; Foster E; Marquina C; Tan A; Pang SST; O'Brien TJ; Kwan P; Jackson GD; Chen Z; Ademi Z
    Neurology; 2023 May; 100(18):e1866-e1877. PubMed ID: 36927880
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Economic and clinical evaluation of vagus nerve stimulation therapy.
    Kopciuch D; Barciszewska AM; Fliciński J; Paczkowska A; Winczewska-Wiktor A; Jankowski R; Steinborn B; Nowakowska E
    Acta Neurol Scand; 2019 Oct; 140(4):244-251. PubMed ID: 31165476
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuromodulation - Science and Practice in Epilepsy: Vagus Nerve Stimulation, Thalamic Deep Brain Stimulation, and Responsive NeuroStimulation.
    Markert MS; Fisher RS
    Expert Rev Neurother; 2019 Jan; 19(1):17-29. PubMed ID: 30526131
    [No Abstract]   [Full Text] [Related]  

  • 38. Is thalamic deep brain stimulation synergistic with vagus nerve stimulation in drug-resistant genetic generalized epilepsy?
    Khan A; Middlebrooks EH; Freund B; Grewal S; Tatum WO
    Epileptic Disord; 2023 Jun; 25(3):406-409. PubMed ID: 36938890
    [TBL] [Abstract][Full Text] [Related]  

  • 39. One-year cost-effectiveness of callosotomy vs vagus nerve stimulation for drug-resistant seizures in Lennox-Gastaut Syndrome: A decision analytic model.
    Abel TJ; Remick M; Welch WC; Smith KJ
    Epilepsia Open; 2022 Mar; 7(1):124-130. PubMed ID: 34890113
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cost-Utility and Cost-Effectiveness Analysis of Spinal Cord Stimulation for Chronic Refractory Pain in the Context of Developing Country.
    Zinboonyahgoon N; Saengsomsuan N; Chaikittiporn N; Wangnamthip S; Kositamongkol C; Phisalprapa P
    Pain Physician; 2023 Jan; 26(1):69-79. PubMed ID: 36791296
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.